Research from the 2024 ASCO Gastrointestinal Cancers Symposium will highlight studies that explore treatment options for people with cancers of the gastrointestinal tract, such as colorectal cancer, esophageal cancer, liver cancer, and neuroendocrine tumors.
Dr. Tingting Zhang shares what people in Asian American and Pacific Islander communities should know about cancer risk, including the types of cancer they may be more at risk for, the importance of screening for these cancers, and resources available to help.
Drs. David Ilson, Sumanta (Monty) Pal, and Tian Zhang discuss new research presented at the 2022 ESMO Congress, including studies about treating liver, colorectal, stomach, kidney, bladder, and prostate cancers.
Oncology dietitian Annette M. Goldberg discusses what nonalcoholic fatty liver disease (NAFLD) is, what causes it, its link to liver cancer, and the steps you can take to prevent NAFLD.
Research from ASCO’s 2022 Gastrointestinal Cancers Symposium will feature 2 abstracts that looked at using immunotherapy to treat advanced liver cancer and biliary tract cancer.
In this podcast, Dr. Andrew Artz and Dr. Jessica Hwang discuss what people with cancer should know about hepatitis B virus, including who should be screened, how to get tested, and how hepatitis B virus can affect people with cancer.
At the 2020 Gastrointestinal Cancers Symposium, research highlights include disparities in care among young adults with colorectal cancer, patient-reported outcomes in liver cancer and colorectal cancer, and a blood-based test to find hard-to-detect cancers.
Organ donation can save lives, including the lives of some people with cancer. Find out how the donation process works and how easy it is to register as a donor.
In this podcast, Dr. Noelle LoConte discusses a recent statement from the American Society of Clinical Oncology that covers the link between drinking alcohol and developing cancer.
